AriseVida Care provides outpatient behavioral health and addiction treatment for adults. Services are based on each person’s needs, clinical assessment, program eligibility, and current availability.

AriseVida Care supports adults experiencing concerns related to opioids, fentanyl, heroin, prescription medications, alcohol, cocaine, methamphetamine, marijuana, and other substances. Our team also supports individuals who may be experiencing both substance use and mental health concerns.

No. You do not need to choose a program on your own. Our admissions team can ask a few initial questions, explain available outpatient services, and help identify the next appropriate step.

Yes. Family members, hospitals, treatment providers, correctional professionals, case managers, and other referral sources may contact us with general questions or referral information. However, privacy laws may limit what our team can share without the patient’s written authorization.

AriseVida Care is an outpatient treatment provider. Eligible intensive outpatient participants may also have access to licensed supportive housing, but supportive housing is not the same as inpatient hospitalization, medical detoxification, or residential treatment.

If an assessment indicates that outpatient treatment is not the safest or most appropriate level of care, the team may recommend or help coordinate a referral to another provider. The goal is to connect each person with care that matches their current needs.

Call AriseVida Care at (602) 899-1229 or submit the website contact form. A team member will review your basic needs, answer initial questions, discuss availability, and explain the next steps.

The admissions team may ask about the type of support you are seeking, current medications, insurance coverage, recent treatment, transportation needs, and any immediate safety concerns. This first conversation helps the team determine which next step may be appropriate.

When available, bring a government-issued photo ID, insurance card, current medication list, pharmacy information, referral or discharge paperwork, and any treatment records requested by the admissions team. The team will let you know if anything additional is needed.

Start dates depend on clinical needs, completion of required paperwork, insurance verification or authorization, provider availability, and program capacity. The admissions team will provide the most accurate timeline after reviewing your situation.

Some individuals contact AriseVida Care directly, while others are referred by a hospital, treatment program, physician, probation or parole professional, case manager, or family member. Referral requirements may vary by service and insurance plan.

Transfers may be possible when clinically appropriate. The process may require signed releases of information, medication or dosing records, recent assessments, insurance verification, and direct coordination between providers. Contact admissions as early as possible so the team can review the required steps.

Availability can change quickly. If the requested program or housing option is full, the team may discuss a waitlist, another appropriate service, or referral options. Placement cannot be guaranteed until admissions confirms availability.

Readmission may be considered based on current needs, clinical appropriateness, previous discharge circumstances, safety, program requirements, and available capacity. Contact admissions so the situation can be reviewed individually.

AriseVida Care works with multiple insurance plans, but accepted coverage may vary by service, program, and current contract status. Visit the Accepted Insurance Plans page or contact admissions for the most current information.

No. Insurance acceptance does not guarantee that every service, medication, level of care, transportation option, or supportive housing arrangement is covered. Benefits, authorizations, medical necessity requirements, deductibles, copayments, and other limitations may apply.

Yes. With your permission and the required insurance information, the admissions team can review available benefits. Insurance verification is not a guarantee of payment, but it can help explain known coverage information before care begins.

No. Asking questions or completing an insurance verification does not obligate you to begin treatment. It is intended to help you better understand your available options.

Possible costs depend on your insurance plan, deductible, copayment, coinsurance, authorization, network status, and the services provided. The team will explain known financial information, but final payment decisions are made by the insurance plan.

Contact admissions to discuss current self-pay options, possible payment arrangements, or outside resources. Available options may vary, and the team cannot guarantee funding or financial assistance. If you are uninsured or will not use insurance, you can request a written Good Faith Estimate of expected charges before care.

No. Clinical treatment benefits and supportive housing arrangements may be reviewed separately. Eligibility, funding, program requirements, and available housing options should be discussed directly with the admissions team.

Notify the team as soon as possible. A change in insurance may affect authorizations, network status, coverage, or patient responsibility. Early notice gives the billing and admissions teams more time to review the new plan.

Medication-assisted treatment, often called MAT, combines FDA-approved medication with counseling, behavioral health services, and recovery support. It may be used to help reduce withdrawal symptoms, cravings, relapse risk, or other substance-related concerns when clinically appropriate.

AriseVida Care offers medication options that may include methadone, buprenorphine products such as Suboxone, oral naltrexone, and extended-release naltrexone such as Vivitrol. Medication selection is based on an individual medical evaluation and provider recommendation.

Methadone is a long-acting opioid medication provided through an opioid treatment program. Suboxone contains buprenorphine and naloxone and may help reduce opioid withdrawal symptoms and cravings. Naltrexone is a non-opioid medication that blocks opioid effects and may also be used for alcohol use disorder. A qualified provider will help determine which option may be appropriate.

No. When prescribed and monitored appropriately, medication-assisted treatment is evidence-based medical care. The medications are used to support stability, reduce risk, and help individuals participate more consistently in treatment and recovery.

Yes, when clinically appropriate. AriseVida Care is MAT-friendly and may combine medication services with intensive outpatient care, counseling, psychiatric care, case management, peer support, and other services.

Medication-assisted treatment should not automatically prevent someone from being considered for supportive housing. Eligibility still depends on the housing program’s requirements, clinical appropriateness, program participation, safety, and current availability.

A transfer may be possible after required records, releases, dosing information, medical information, and coordination are completed. Do not stop attending your current clinic until the transfer has been formally approved and a start date has been confirmed.

Courtesy dosing may be considered when coordinated in advance between opioid treatment programs. It generally requires clinical approval, signed releases, verified dosing information, and confirmation from the receiving clinic. Contact the nursing team as early as possible.

Take-home eligibility is based on applicable regulations, clinical stability, attendance, medication safety, treatment progress, provider judgment, and other program requirements. Take-home schedules are not guaranteed and may change when clinically or legally necessary.

Certain medications, including naltrexone, may be used for alcohol use disorder when clinically appropriate. A medical provider must review medical history, current alcohol use, medications, and treatment goals before recommending an option.

Do not start, stop, or change a prescribed medication without instructions from a qualified medical provider. Bring an accurate medication list and discuss any concerns with the treatment team.

An Intensive Outpatient Program, or IOP, provides structured treatment several days per week without requiring an overnight stay in a treatment facility. Services may include group counseling, individual support, education, relapse-prevention planning, case management, and coordination with medical or psychiatric care.

The schedule depends on the program and clinical recommendation. AriseVida Care offers an outpatient IOP option that may meet three days per week. Participants receiving supportive housing are expected to participate in the five-day IOP schedule.

AriseVida Care aims to provide work-friendly outpatient treatment when scheduling and clinical needs allow. Speak with admissions about current group times and any employment, school, court, or family obligations.

Groups may address recovery skills, triggers, coping strategies, relapse prevention, emotional regulation, communication, healthy routines, substance-use education, and other topics connected to treatment goals. Participants are expected to engage respectfully and maintain confidentiality.

Individual, group, and family counseling may be included when clinically appropriate and available. The treatment team will explain which services are part of the individual treatment plan.

IOP is an 18-week program comprising 90 scheduled weekday program days. Individual length of participation can vary based on clinical needs, attendance, progress, insurance authorization, treatment-plan goals, safety, and the recommended next level of care.

Drug and alcohol testing may be used as part of treatment, medication monitoring, safety planning, and clinical decision-making. Frequency and type of testing depend on the program, treatment plan, medication, and clinical circumstances.

IOP is outpatient care, meaning participants return home or to supportive housing after programming. Residential treatment provides treatment and supervision in a live-in clinical setting. The appropriate level of care depends on safety, stability, medical needs, and clinical assessment.

If the team believes a higher level of care is needed, they may recommend detoxification, residential treatment, hospitalization, or another service. Recommendations are made to support safety and appropriate treatment.

Psychiatric services may include evaluation, diagnosis, medication review, medication management, symptom monitoring, and coordination with counseling or substance-use treatment. Services are based on clinical eligibility and provider availability.

Yes. Many individuals experience co-occurring mental health and substance-use concerns. AriseVida Care uses a whole-person approach and may coordinate psychiatric care, therapy, medication-assisted treatment, IOP, and support services when appropriate.

No medication should be started without discussion and informed consent. A psychiatric provider can explain potential benefits, risks, alternatives, and monitoring needs so the patient can participate in treatment decisions.

Deep transcranial magnetic stimulation, or Deep TMS, is a noninvasive treatment that uses magnetic stimulation to target areas of the brain associated with certain mental health conditions. Eligibility is determined through a clinical and medical evaluation.

No. Eligibility depends on diagnosis, treatment history, medical conditions, implanted devices, medications, safety considerations, and other clinical factors. A qualified provider must complete an evaluation before treatment begins.

When clinically appropriate, psychiatric care or Deep TMS may be coordinated with counseling, IOP, medication-assisted treatment, case management, and other services. The treatment plan should reflect the individual’s needs and provider recommendations.

Routine outpatient appointments are not a replacement for emergency care. Anyone experiencing an immediate medical or psychiatric emergency should call 911 or go to the nearest emergency department. In the United States, call or text 988 for crisis support.

AriseVida Care offers access to its own licensed supportive housing for eligible intensive outpatient participants. Housing availability, eligibility, placement, and continued residence depend on program requirements and current capacity.

No. Supportive housing provides a structured, recovery-oriented living environment, but it is not inpatient or residential clinical treatment. Clinical services are provided through the outpatient treatment program.

Supportive housing may be considered for adults participating in the appropriate AriseVida Care IOP schedule who meet program, safety, behavioral, and housing eligibility requirements. Placement is not guaranteed and depends on current availability.

Yes. Supportive housing is connected to active program participation. Residents are expected to attend required treatment, follow house rules, participate in recovery-focused activities, and maintain appropriate conduct.

AriseVida Care directly provides transportation primarily for IOP participants when available and connected to program needs. For individuals receiving non-IOP services, the team may help coordinate transportation through the person’s insurance plan when that benefit is available.

Case management may help patients stay connected to appointments, referrals, documents, community resources, benefits, treatment recommendations, and other practical needs related to ongoing care. The exact level of assistance depends on individual needs and available resources.

Peer support is provided by trained individuals who use relevant lived experience and recovery knowledge to offer encouragement, practical guidance, accountability, and connection. Peer support complements clinical treatment but does not replace therapy or medical care.

Justice reentry support may help eligible individuals connect with treatment, medication services, case management, supportive resources, appointments, documentation, and recovery planning after release. Services depend on the individual’s needs and program eligibility.

Aftercare may include continued outpatient services, medication follow-up, counseling, case management, peer support, relapse-prevention planning, referrals, and connection to community resources. Recommendations are individualized.

AriseVida Care aims to provide practical, work-friendly outpatient care when possible. Available schedules still depend on the service, group times, clinical recommendation, provider availability, and program requirements.

Contact the appropriate staff member as soon as possible. Attendance is an important part of treatment, and repeated or unexplained absences may affect medication services, program participation, insurance authorization, housing eligibility, or the treatment plan.

Family involvement may be included when clinically appropriate and when the patient provides the required consent. Privacy laws generally prevent staff from sharing protected information without authorization.

AriseVida Care may provide or coordinate services in English, Spanish, and Russian. Language availability can vary by staff member, appointment type, and service, so needs should be discussed during admissions.

Communication may be possible when a valid release of information is signed or when disclosure is otherwise legally permitted or required. The team will explain what information may be shared and with whom.

Yes, in many situations. Patients should provide accurate information about outside providers, medications, pharmacies, and treatment so the care team can coordinate safely and reduce the risk of conflicting recommendations.

The first day may include registration, consent forms, assessments, medical or psychiatric review, orientation, medication verification, treatment planning, and an introduction to program expectations. The exact process depends on the services being started.

AriseVida Care protects patient information in accordance with applicable privacy laws and confidentiality requirements. Information is generally not shared without written permission unless disclosure is permitted or required by law.

Staff may be limited in what they can confirm or discuss without a signed authorization. Patients may choose which individuals or organizations are authorized to receive information and what information may be shared.

In many situations, a patient may update or revoke a release in writing. Revocation does not undo information that was already shared while the release was valid, and certain legal exceptions may apply.

Do not use the website contact form for emergencies. Call 911 or go to the nearest emergency department. For mental health or suicide-related crisis support in the United States, call or text 988.

Call 911 immediately. Administer naloxone if it is available and you are able to do so, follow emergency-dispatch instructions, and remain with the person until help arrives. Do not assume the person will recover without medical attention.

Patients have the right to raise concerns without retaliation. Contact a staff member, supervisor, or the appropriate program representative. Information about patient rights, grievances, and outside complaint resources should also be provided during admission.

No. Website forms and general email messages may not be reviewed immediately and should never be used for emergencies, urgent medication concerns, or crisis situations.

The treatment team may recommend a step-down plan based on progress and ongoing needs. This may include standard outpatient counseling, medication follow-up, psychiatric care, peer support, case management, recovery meetings, or community referrals.

Medication treatment may continue when clinically appropriate and when program requirements are met. Completing IOP does not automatically mean medication must stop. A medical provider should guide any medication changes.

Contact the treatment team as soon as possible. A return to use does not mean recovery is impossible. The team may review safety, medication needs, triggers, treatment intensity, testing, housing considerations, and whether another level of care is needed.

Yes. Services may increase, decrease, or change based on clinical needs, progress, safety, attendance, insurance authorization, and treatment goals. Any recommended change should be discussed with the patient.

Yes. When a needed service is outside AriseVida Care’s scope or another level of care is more appropriate, the team may help provide referral information or coordinate with another provider when permitted.

Call AriseVida Care at (602) 899-1229 or submit the contact form. A team member can answer general questions and help explain the next appropriate step.